chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Uncontrollable bladder.  On 8/4/21 when getting out of bed my bladder immediately emptied and I ended in a puddle on the floor.  This continued throughout the next two days, subsiding on Saturday but resurfacing on Sunday and a slight amount of blood was evident on the pad but not in the urine.  I went to urgent care, on 8/7 tested for UTI but no culture found.  I was also experiencing severe back pain.  I visited my primary care office on 8/9 and was referred to spine physician and radiologist and MRI and additional x-rays.  Additionally it was suggested that I see an urologist to examine the reason for the uncontrollable bladder which I did 9/28 but no diagnosis was provided. I am sending this because recently I was told by a friend that the same set of circumstances that happened to me also happened to her mother.  In her case she was told that the incontinence was caused by two medications she was taking. In my case the diagnosis was not definite but a guess of kidney stones was a possibility.  The problem has resolved by itself but it took a couple of months to get back to normal.  I do not have an incontinence problem on a normal basis. This was more than incontinence - the bladder completely let go like a flood. Also, in April, approximately two months after vaccine I was doing some yard work.  I moved a timber that had some black ants on it and much to my surprise I was bitten.  I wasn't initially concerned when I saw the ants because they were black and I'm familiar with fire ants.  In any event, within minutes I became dizzy, blurred vision, unable to stand so I sat down which I think kept me from passing out completely and then I had to crawl up my steps to get into the house.  After resting for a short time I was back to normal again and out working in the yard in the afternoon.  Again, I'm telling you this story because just a week ago or so my daughter told me that the same thing happened to a man at a retail store she was at.  He has been standing in line with his shoes off on the grass (waiting for store to open) and got bitten by some ants.  He started called for help and demonstrated all the same things that I had but he actually passed out and had to be taken by ambulance.  Mayabe nothing but both kind of strange and then stranger that even one other person had the exact same experience.
It was reported that a 70 y.o. male PT received a TD adult vaccination, a Typhim Vi vaccination and an Twinrix vaccination on 9/10/01 at 2 p.m. Reportedly on 9/15/01 at approximately 2 p.m. the PT developed an itchy red rash on buttocks and legs. PT took Benadryl as treatment with modified relief. PT contacted MD's office on 9/19/01 w/no further treatment. It was reported that the PT ingested raspberries on the day the rash appeared. The PT recovered from this experience. See report U2001-01170, same reporter.
Fever to 101 F. Cyanosis, apnea estimated to last 30 seconds. Infant co-sleeping with mother who awoke to discover infant as above. Stimulation required. 12/17/07-records received for DOS 11/21-11/23/07-DC DX: Apparent life threatening event, rule out sepsis. Presented to ED after having episode where he turned blue and stopped breathing for approximately 30 seconds according to his parents. Developed fever up to 101 rectaly, some vomiting. No stool for 2 days. Noticed some eye rolling.
Significant local reaction on L arm, red and swollen 6 cm in size encompassing the whole arm.
This spontaneous report received from a patient via another pharmaceutical company concerned a 20 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe chronic plaque psoriasis. The patient had previously received 2 doses of Moderna covid-19 vaccine (elasomeran) (dose number in series 1) (form of admin not reported, intramuscular, batch number: unknown expiry: unknown) dose was not reported, administered on 15-APR-2022 (dose 1) and on 15-JUN-2020 (dose 2) for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with 2 doses of Moderna covid-19 vaccine (elasomeran) (dose number in series 1). The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, intramuscular, batch number was not reported) dose was not reported, 1 in total, administered on 11-SEP-2021 for covid-19 prophylaxis which was an off label dosing frequency (dose number in series 2). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. The drug was associated with Off label use. Age at time of vaccination 19 years old. No concomitant medications were reported.  The patient received non-company suspect drugs included: adalimumab (suspension for injection in pre-filled pen, subcutaneous, batch number was not reported) Citrate free, dose, frequency, and therapy dates were not reported for moderate to severe chronic plaque psoriasis. On JUL-2022, the patient experienced covid-19, ear infection, and ear discharge (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient had not recovered from covid-19, ear infection, and ear discharge, and the outcome of off label dosing frequency was not reported. This report was non-serious.
This spontaneous report was received from an office manager and refers to an unspecified number of patients of unknown ages and genders. On an unknown date, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 lot # N011305 for prophylaxis. No adverse effects were reported.
A fluid sack developed under the left arm in the arm pit and up into a portion of the bicep . Arm pit is tender. Slight fever and rash on left arm under the injection site.
This spontaneous case was initially received on 20-OCT-2015. The case report was received from a(n) Health Professional and concerns a(n) 69 year old female patient. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received an Unspecified influenza vaccine on unknown dates, Batch no: not provided, Route of administration:  Unknown, Dose: no information provided. Additional suspect drug(s): On the same day, the patient also received ZOSTAVAX. Reaction(s)/event(s) and outcome: On an unknown date, after starting/treatment with Unspecified influenza vaccine the patient experienced redness of the arm (non serious, outcome: Unknown) Reporter's assessment: Not reported.
Patient was anxious and nervous, rubbing back of head. Developed nausea and went into the bathroom unattended.  Dizziness while in bathroom; fainted and fell to floor hitting head.
administration date=11/Feb/2021; administration date=11/Oct/2021; Development of atopic dermatitis (of the scalp) 1-2 months after second dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Feb2021 08:30 (Lot number: EL3248) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ORTHO TRI-CYCLEN; DUPIXENT. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: 301308A, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), for COVID-19 immunization. The following information was reported: DERMATITIS ATOPIC (medically significant) with onset Apr2021, outcome "not recovered", described as "Development of atopic dermatitis (of the scalp) 1-2 months after second dose."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "administration date=11/Feb/2021; administration date=11/Oct/2021". The event "development of atopic dermatitis (of the scalp) 1-2 months after second dose." was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (20Feb2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of dermatitis atopic. It was unknown if therapeutic measures were taken as a result of inappropriate schedule of product administration.The patient had report about covid vaccine. Patient had no any other vaccine in four weeks. Ae resulted in [Doctor or other healthcare professional office/clinic visit]. Ae treatment Multiple topical steroids, oral prednisone, Dupixent. Patient had no covid prior vaccination. Patient tested covid post vaccination. covid test type post vaccination was nasal Swab.  No follow-up attempts are possible. No further information is expected.
Injection site became swollen, red - size of softball 6 inch by 8 inches, redness 4 days, tender to touch.
This spontaneous report was received from a registered nurse referring to some patients of unknown age and gender, that were vaccinated, on an unknown date, with a dose of GARDASIL, 0.5 ml, intramuscular (lot # not reported). Information regarding concomitant therapy, concurrent conditions and medical history was not provided. The nurse reported that the GARDASIL was administered to patients post supported excursion. No adverse effects noted by any patient. This is one of several reports from the same reporter source. Additional information has been requested.
Within an hour of the shot, started feeling dizzy.  Intense fatigue and full body aches set in within 3 hours.  Facial numbness and left-side facial drooping began within 8 hours.  Low fever, chills, heavy heart beat, and intermittent cramps of the abdomen and on the left side (between hip and rib cage) began within 18 hours.  Swollen lymph nodes in the neck and constipation began within 48 hours.  At ~4 days since the first shot, the facial numbness, heavy heart beat, and fatigue persisted, though the drooping became less prominent and the other symptoms have largely resolved.  At ~2 weeks since the first shot, the facial numbness has been constant, but varying in intensity, and the left-side facial drooping has returned multiple times.
Information has been received from a physician concerning a female who on 22-DEC-2008 was vaccinated with the first dose of GARDASIL vaccine. On 18-FEB-2009, was vaccinated with the second dose of GARDASIL vaccine. On 18-FEB-2009, the patient experienced fever and joint pain after the second dose. No adverse reactions were reported after the first dose of GARDASIL vaccine. At the time of the report the patient was recovered. The patient sought medical attention. Additional information has been requested.
Found out I had COVID-19 on 10/07/2021. Also, was experiencing a right ear infection, also while receiving the COVID-19 test, I found out I had bronchitis; For the infections, I was prescribed two rounds of the antibiotics. After receiving the vaccine, I didn't have a reaction, I just felt very fatigued. I still feel fatigued after catching COVID-19, and bronchitis and ear infection.
5 x 2 cm erythematous edematous over at varicella injection site 10 days after injection. Treated with BACTRIM x 10 days.
she has had them take one of the 9 valent at age 17 as a booster; she has had them take one of the 9 valent at age 17 as a booster; No additional AE; This spontaneous report was received from a consumer and referred to a 17-year-old patient of unknown gender (one of twins). The patient's medical history, concurrent condition, and concomitant therapy were not reported.  On an unknown date (at age 11 of patient), when disease control said the patient only needed the two doses' series, the patient received 2 of quadrivalent human papillomavirus (types 6,11,16,18) recombination vaccine (4 valent) (GARDASIL) (strength, dose description, lot#, expiry date, and route of administration were not provided) for prophylaxis. On an unknown date (at age 17), the patient took one of the HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (9 valent) (GARDASIL 9) (strength, dose description, lot#, expiry date, and route of administration were not provided) for prophylaxis as a booster (Interchange of vaccine products) (Inappropriate schedule of vaccine administered). The reporter provided no further information. There was no additional adverse event.  This is one of two reports received from the same reporter.
Notice little pin point red dots that appeared  a couple of days where I received the injection. A few days later I notice serval long red lines appear above, in and under my underarm on the side I had the injection. They resembled in appearance like long scratch lines but they were not stratches.
pt recv vax 29JUL97 & same day pt devel arthralgias w/o arthritis;
Vaccine administered to patient after temperature excursion; No adverse event; Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Feb-2023, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion).    No concomitant medication was reported.  Vaccine were provided from the lot number. 061F22A. No calls from patient in regards to side effects from the temperature excursion. No treatment information was reported.
Patient received fluzone hd and is not 65 years of age. Patient was contacted and we talked about adveres effects/reactions , he has reported NO signs/symptoms of adverse effects, but was told to contact us if anything occurs. We looked up the package insert and patient does not require an addition flu shot.
Fully vaccinated, not boosted. Symptomatic COVID infection breakthrough in an immunosuppressed oncology patient
At 8 days after the shot , the sight was itchy, red, warm to the touch and hard and swollen!
Nausea, loss of consciousness, hypotension, palor- all with in 15 minutes  following vaccine
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 11Aug2023 and 15Aug2023. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a female with a history of eggs allergy as a child and previous reaction to flu vaccination "many years ago" who was vaccinated in the deltoid muscle with a dose of pneumococcal vaccine 23 polyvalent. Subsequently, the pt developed a severe injection site reaction with swelling down to wrist. Additional information has been requested.
Received Pfizer vaccines on 8/9, 8/31/21 COVID-19 positive by PCR on  1/5/22 admitted to hospital on 1/7/22 d/t suicidal ideation, found to be COVID positive
Pt. received flu shot and site immediately began to swell. A lump formed at the site and increased. Pt. stated heart was racing, no shortness of breath. Neck became blotchy and red. 911 was called. Epi was given 1 dose at the site. Paramedics responded and took pt. to hospital.  2/2/09 MR received for ER visit 10/1/08 with DX:  Medication reaction. Pt developed local reaction, chest tightness and redness to neck and chest after receipt of Flu shot. Epipen given on scene after which pt became tachycardic at 160 BPM.  Chest tighness resolving on arrival to ER.  In sinus tach on arrival. Ice placed on hard area at injection site. Tx with Benadryl and D/C
Around three days after vaccination, I (the patient) suddenly developed significant atopic dermatitis on my arms, legs, and genitals. The location of most severe symptoms was on the knee pits and elbow pits. The skin became red, bumpy, broken, and leaked a significant amount of yellow/clear fluid. The symptoms were not unlike poison ivy but less localized. I (the patient) had not experienced similar symptoms at any point prior and was in good health/not immunocompromised at the time of vaccination. Similar symptoms were not experienced at the time of the first dose being administered. Benadryl and a hydrocortisone cream were used to alleviate symptoms with little success. The symptoms have continued for around a week and have showed signs of improvement.
Patient was given monovalent Pfizer 12+ instead of monovalent Pfizer 5-11.
Within a couple of weeks of receiving  the second covid vaccine pain in my hands and new symptoms in my feet had  gotten worse. Bedtime was excruciating. Rheumatoid doctor had diagnosed me  with Fibromyalgia but referred me to a neurologist once I developed new symptoms and chronic pain was worse.  After multiple tests and biopsy's the neurologist diagnosed me with small fiber neurology.
I am currently 22 weeks pregnant. It is my 4th pregnancy. I have had 2 live births and 1 miscarriage previous.   About 24 hours post my injection, I received a high resting heart rate alert from my Watch while resting. I was not moving around or exerting myself. No dizziness or shortness of breath. I manually checked my heart rate and it stayed greater than 130 for about 30 minutes. It seemed regular, just tachy. My normal resting heart rate is in the 70?s. I did feel some heart racing but nothing unnerving. After about 30 minutes it gradually returned to baseline. No issues since.
I had swollen lymph glands in my throat under my jaw, not in my armpit or under my ears. Just under the jaw and behind my throat. They were painful and the strangest part is that the pain would travel across my teeth. It was really strong painful feeling from my lymph nodes to my teeth. They were palpable to my doctor, and they were swollen. He had me get a throat soft tissue ultrasound and that was normal. No one was thinking that it was a vaccine reaction. It was two weeks since my vaccine and it was getting much worse. The feeling was getting really strong. He had me go to the dentist and they did a pano x-ray. And there was nothing there.  Gradually it got really bad at two weeks. That was at it?s strongest. There was also blood work done for inflammatory markers and there was nothing there either. After they told me I was fine, I just didn?t worry about it anymore and it eventually went away. It was very strange, and the lymph glands felt like they were the ones that connected to your teeth right under your jaw. It hurt a lot. The swollen lymph nodes may have pinched a nerve or something, but unsure.
Chest pain, muscle fatigue, nausea, headache, disorientation, and chills all developed approximately 13 hours after injection.  Chest pain worsened and loss of feeling in all four extremities at approximately 0930.  EMS called at 0950 and conducted EKG and medical assessment.  No cardiac event seen and no explanation for pain.  Chest pain eventually lessened but continues to persist.
PT WAS GIVEN AN EXTRA DOSE OF KINRIX IN HER RT ARM. MOM CALLED TO REPORT THAT CHILD HAS A REDDENED AREA 4IN BY 2IN THAT WAS HOT TO TOUCH.
CONSTANT PAIN IN ARM; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on OCT-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On OCT-2021, the patient experienced constant pain in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from constant pain in arm. This report was non-serious.
Patient was seen for her well child exam on 4/3/2008 at 9am.  She received her DTaP vaccine in her left deltoid.  The following morning on 4/4/08, she woke up and had erythema and swelling at this site, measuring 7 by 7 cm on my examination today.  The site was round, well-circumscribed, and mildly tender to palpation.  Her temperature in the office was 99.6F.  She was otherwise well appearing and discharged home from the office with symptomatic care for this immunization reaction (Tylenol or Motrin for discomfort, cool compresses, recheck next week if not resolving).